Resultados de la búsqueda 51-60 of 4409 for treatment resistant depression

  1. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn., ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ... Treat Subjects with Relapsed or Refractory ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...

  5. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... treatment) in the breast in patients who have ... Resistant, Triple Negative Breast Cancer ... care that includes regional radiation therapy, with receiving no ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia. Patients ... treatment, post ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    ... Treat Subjects with Relapsed or Refractory ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia.

  9. Epic Billing Statement MC232375

    Page 1. Page 2.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purose of this study is to evaluate the effiectiveness, safety, and pharmacokinetics of tirabrutinib monotherapy in patients with relapsed or refractory ...